Combination Therapy for the Treatment of Diffuse Midline Gliomas

Clinical trial NCT05009992 · RECRUITING

Trial details

NCT number: NCT05009992
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma, H3 K27M-Mutant Recurrent Diffuse Intrinsic Pontine Glioma Recurrent Diffuse Midline Glioma, H3 K27M-Mutant Recurrent WHO Grade III Glioma WHO Grade III Glioma

Start date: 2021-10-20
Primary completion: 2027-12-31
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.